Healthcare provider profile · identity verified

Manpreet Kaur, NP-C

Nurse Practitioner · INKSTER, MI · NPI 1326514944

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	548	169
Lisinopril	Lisinopril	299	90
Losartan Potassium	Losartan Potassium	285	84
Amlodipine Besylate	Amlodipine Besylate	239	84
Levothyroxine Sodium	Levothyroxine Sodium	210	49
Metoprolol Succinate	Metoprolol Succinate	197	68
Omeprazole	Omeprazole	190	63
Albuterol Sulfate Hfa	Albuterol Sulfate	181	63
Metformin Hcl	Metformin Hcl	142	48
Pantoprazole Sodium	Pantoprazole Sodium	134	39
Gabapentin	Gabapentin	129	29
Metoprolol Tartrate	Metoprolol Tartrate	102	35
Simvastatin	Simvastatin	101	31
Eliquis	Apixaban	95	22
Furosemide	Furosemide	85	34
Hydralazine Hcl	Hydralazine Hcl	82	22
Clopidogrel	Clopidogrel Bisulfate	81	26
Famotidine	Famotidine	81	34
Ibuprofen	Ibuprofen	80	30
Trazodone Hcl	Trazodone Hcl	78	27
Hydrochlorothiazide	Hydrochlorothiazide	77	27
Duloxetine Hcl	Duloxetine Hcl	76	22
Tamsulosin Hcl	Tamsulosin Hcl	74	25
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	71	21
Carvedilol	Carvedilol	70	22
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	68	19
Fluticasone Propionate	Fluticasone Propionate	66	40
Sertraline Hcl	Sertraline Hcl	64	18
Rosuvastatin Calcium	Rosuvastatin Calcium	56	14
Allopurinol	Allopurinol	53	14
Glimepiride	Glimepiride	53	14
Spironolactone	Spironolactone	51	19
Jardiance	Empagliflozin	47	19
Potassium Chloride	Potassium Chloride	46	15
Glipizide	Glipizide	44	15
Breo Ellipta	Fluticasone/Vilanterol	40	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	40	12
Meloxicam	Meloxicam	38	13
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	36	17
Pregabalin	Pregabalin	35	suppressed
Atenolol	Atenolol	34	11
Farxiga	Dapagliflozin Propanediol	34	suppressed
Montelukast Sodium	Montelukast Sodium	34	11
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	33	suppressed
Trulicity	Dulaglutide	33	11
Chlorthalidone	Chlorthalidone	32	suppressed
Donepezil Hcl	Donepezil Hcl	32	suppressed
Ozempic	Semaglutide	32	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	31	13
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	30	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	30	12
Primidone	Primidone	30	suppressed
Ventolin Hfa	Albuterol Sulfate	30	suppressed
Warfarin Sodium	Warfarin Sodium	30	suppressed
Citalopram Hbr	Citalopram Hydrobromide	29	suppressed
Ezetimibe	Ezetimibe	29	suppressed
Memantine Hcl	Memantine Hcl	29	suppressed
Buspirone Hcl	Buspirone Hcl	28	11
Divalproex Sodium	Divalproex Sodium	28	suppressed
Metformin Hcl Er	Metformin Hcl	28	suppressed
Nifedipine Er	Nifedipine	28	suppressed
Symbicort	Budesonide/Formoterol Fumarate	26	suppressed
Tramadol Hcl	Tramadol Hcl	25	15
Lactulose	Lactulose	24	suppressed
Meclizine Hcl	Meclizine Hcl	24	suppressed
Ondansetron Hcl	Ondansetron Hcl	24	11
Oxybutynin Chloride Er	Oxybutynin Chloride	24	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	24	suppressed
Clonidine Hcl	Clonidine Hcl	23	suppressed
Folic Acid	Folic Acid	23	suppressed
Glipizide Er	Glipizide	23	suppressed
Januvia	Sitagliptin Phosphate	23	suppressed
Methylprednisolone	Methylprednisolone	23	22
Novolog Flexpen	Insulin Aspart	23	suppressed
Tizanidine Hcl	Tizanidine Hcl	23	11
Tradjenta	Linagliptin	23	suppressed
Alprazolam	Alprazolam	22	suppressed
Diclofenac Sodium	Diclofenac Sodium	22	suppressed
Entresto	Sacubitril/Valsartan	22	suppressed
Pravastatin Sodium	Pravastatin Sodium	22	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	21	19
Bumetanide	Bumetanide	21	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	21	14
Celecoxib	Celecoxib	20	suppressed
Easy Touch Alcohol Prep Pads	Alcohol Antiseptic Pads	20	suppressed
Hydrocortisone	Hydrocortisone	20	suppressed
Linzess	Linaclotide	20	suppressed
Mirtazapine	Mirtazapine	20	suppressed
Azithromycin	Azithromycin	19	18
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	19	suppressed
Valacyclovir	Valacyclovir Hcl	19	suppressed
Alendronate Sodium	Alendronate Sodium	18	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	18	11
Baclofen	Baclofen	17	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Loperamide	Loperamide Hcl	17	suppressed
Nitroglycerin	Nitroglycerin	17	suppressed
Risperidone	Risperidone	17	suppressed
Sucralfate	Sucralfate	17	suppressed
Bupropion Xl	Bupropion Hcl	16	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	16	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	16	suppressed
Lovastatin	Lovastatin	16	suppressed
Prednisone	Prednisone	16	14
Ropinirole Hcl	Ropinirole Hcl	16	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	16	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	15	15
Fenofibrate	Fenofibrate	15	suppressed
Midodrine Hcl	Midodrine Hcl	15	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	15	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	15	15
Ketoconazole	Ketoconazole	14	suppressed
Methocarbamol	Methocarbamol	14	11
Myrbetriq	Mirabegron	14	suppressed
Naproxen	Naproxen	14	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	13	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	13	13
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	13	suppressed
Nystatin	Nystatin	13	suppressed
Paroxetine Hcl	Paroxetine Hcl	13	suppressed
Xarelto	Rivaroxaban	13	suppressed
Acyclovir	Acyclovir	12	suppressed
Finasteride	Finasteride	12	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	12	suppressed
Ondansetron Odt	Ondansetron	12	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	12	suppressed
Alcohol Swabs	Alcohol Antiseptic Pads	11	suppressed
Constulose	Lactulose	11	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	11	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	11	suppressed
Quetiapine Fumarate Er	Quetiapine Fumarate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error